Correlation Between SCANDMEDICAL SOLDK and ALBIS LEASING

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SCANDMEDICAL SOLDK and ALBIS LEASING at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SCANDMEDICAL SOLDK and ALBIS LEASING into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SCANDMEDICAL SOLDK 040 and ALBIS LEASING AG, you can compare the effects of market volatilities on SCANDMEDICAL SOLDK and ALBIS LEASING and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SCANDMEDICAL SOLDK with a short position of ALBIS LEASING. Check out your portfolio center. Please also check ongoing floating volatility patterns of SCANDMEDICAL SOLDK and ALBIS LEASING.

Diversification Opportunities for SCANDMEDICAL SOLDK and ALBIS LEASING

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between SCANDMEDICAL and ALBIS is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding SCANDMEDICAL SOLDK 040 and ALBIS LEASING AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ALBIS LEASING AG and SCANDMEDICAL SOLDK is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SCANDMEDICAL SOLDK 040 are associated (or correlated) with ALBIS LEASING. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ALBIS LEASING AG has no effect on the direction of SCANDMEDICAL SOLDK i.e., SCANDMEDICAL SOLDK and ALBIS LEASING go up and down completely randomly.

Pair Corralation between SCANDMEDICAL SOLDK and ALBIS LEASING

Assuming the 90 days horizon SCANDMEDICAL SOLDK 040 is expected to under-perform the ALBIS LEASING. In addition to that, SCANDMEDICAL SOLDK is 6.67 times more volatile than ALBIS LEASING AG. It trades about -0.04 of its total potential returns per unit of risk. ALBIS LEASING AG is currently generating about 0.11 per unit of volatility. If you would invest  272.00  in ALBIS LEASING AG on September 20, 2024 and sell it today you would earn a total of  6.00  from holding ALBIS LEASING AG or generate 2.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

SCANDMEDICAL SOLDK 040  vs.  ALBIS LEASING AG

 Performance 
       Timeline  
SCANDMEDICAL SOLDK 040 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SCANDMEDICAL SOLDK 040 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
ALBIS LEASING AG 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in ALBIS LEASING AG are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, ALBIS LEASING is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

SCANDMEDICAL SOLDK and ALBIS LEASING Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SCANDMEDICAL SOLDK and ALBIS LEASING

The main advantage of trading using opposite SCANDMEDICAL SOLDK and ALBIS LEASING positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SCANDMEDICAL SOLDK position performs unexpectedly, ALBIS LEASING can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALBIS LEASING will offset losses from the drop in ALBIS LEASING's long position.
The idea behind SCANDMEDICAL SOLDK 040 and ALBIS LEASING AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments